|This information is provided free of charge by the Department of Industrial Relations from its web site at www.dir.ca.gov. These regulations are for the convenience of the user and no representation or warranty is made that the information is current or accurate. See full disclaimer at http://www.dir.ca.gov/od_pub/disclaimer.html.
Subchapter 7. General Industry Safety Orders
Group 16. Control of Hazardous Substances
Article 109. Hazardous Substances and Processes
Diacetyl report of use form
§5197. Occupational Exposure to Food Flavorings Containing Diacetyl.
(a) General Requirements.
(A) This section applies to all places of employment where food products or flavorings are manufactured, processed or used and one or more processes in the establishment utilize diacetyl or food products or flavorings that contain diacetyl at a concentration of 1% or more by weight.
(B) This section also applies in part, as set forth in subsection (a)(2), to any place of employment utilizing food products or flavorings that contain diacetyl or other artificial butter flavoring at any concentration, and an employee has been diagnosed as having a work-related fixed obstructive lung disease.
(A) All employers meeting conditions identified in subsection (a)(1)(A) shall comply with all requirements of this Section.
(B) Each employer meeting the conditions identified in subsection (a)(1)(B) shall do all of the following in regard to the diagnosed employee:
1. Subject the employee to medical surveillance pursuant to subsection (g) of this standard,
2. Obtain a written opinion from the PLHCP pursuant to subsection (h),
3. Comply with the provisions of subsection (i), and
4. Report the diagnosis to the Division pursuant to subsection (k)(2).
(3) Pursuant to Section 332.3, the Division may require an employer identified in subsection (a)(1)(B) to take additional actions to protect employees against exposure to diacetyl or other artificial butter flavor.
(4) The employer shall provide all safeguards required by this section, including provision of personal protective equipment, respirators, training, and medical surveillance and management in accordance with subsections (g) through (i), at no cost to the employee, at a reasonable time and place for the employee, and during the employee's working hours.
NOTES to Section 5197:
1. This section does not preclude the application of other sections of Title 8 including, but not limited to, Sections 3203, 3204, 5141, 5143, 5144, 5155, and 5194.
2. None of the requirements in Section 5197, in particular those described in subsections (g), (h), or (i), supplant or otherwise contradict the rights, privileges, and obligations set forth in Division 4 of the Labor Code (commencing with section 3200), regarding workers' compensation. The requirements in subsections (g), (h), and (i), for medical surveillance, physician opinions regarding an employee's physical condition and work limitations, and medical removal, are supplemental, additional, or complementary to any medical evaluation or indemnity payment procedure required or specified in Division 4 of the Labor Code. The fact that a medical opinion is provided or an employer action is taken pursuant to Section 5197 shall have no bearing on whether the opinion or action is determinative of rights or benefits provided under Division 4 of the Labor Code.
(1) “American Thoracic Society Guidelines” means “ATS/ERS Task Force: Standardisation of Lung Function Testing,” a five part series published jointly in 2005 by the American Thoracic Society [ATS] and the European Respiratory Society in five consecutive issues of the European Respiratory Journal.
(2) “Authorized person” means any person specifically authorized by the employer and required by work duties to be present in regulated areas, or any person entering such an area as a designated representative of employees for the purpose of exercising the right to observe monitoring and measuring procedures, or the Chief.
(3) “CDPH Guidelines” means “Medical Surveillance for Flavorings-Related Lung Disease Among Flavor Manufacturing Workers in California,” published in August 2007 by the California Department of Public Health (CDPH).
(4) “Certified industrial hygienist (CIH)” means an industrial hygienist who is certified by the American Board of Industrial Hygiene.
(5) “Chief” means the Chief of the Division of Occupational Safety and Health, or designee.
(6) “Diacetyl” means the substance that is also known as 2,3-Butanedione and has CAS (Chemical Abstract Service) #431-03-8. “Diacetyl” also means a proprietary formulation containing diacetyl, e.g., diacetyl starter distillate [Chemical Abstract Service (CAS) #977019-27-4] unless the manufacturer indicates through the accompanying material safety data sheet (MSDS) or through other written means that the material contains less than one percent diacetyl by weight.
(7) “Diacetyl-containing” means containing diacetyl at a concentration of 1% or more by weight.
(8) “Enclosed process” means a process that is completely enclosed and from which all emissions are conveyed to a suitable point of safe disposal as verified by an exposure assessment conducted in accordance with subsection (c) and certified in accordance with subsection (e)(6). A process is not enclosed if there are any visible emissions.
(9) “Equivalent method” means a sampling and analytical method for diacetyl that has been fully validated by the United States Department of Labor's Occupational Safety and Health Administration (OSHA) or NIOSH as being at least as accurate, specific and sensitive as the OSHA Method and has an RQL less than or equal to the OSHA RQL or a sampling and analytical method for diacetyl that has been determined to be acceptable by the Chief.
(10) “Fixed obstructive lung disease” means a medical condition diagnosed by a PLHCP in an individual for whom spirometry has shown fixed airways obstruction. Airways obstruction is defined by a ratio of forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) and an FEV1 value which are both below the lower limit of normal (LLN) as determined by the 95% confidence limits of the values published in “Spirometric Reference Values.” Airways obstruction is considered fixed when, after the passage of 10 to 20 minutes following administration of 4 puffs of albuterol using a spacer or volume chamber, FEV1 does not increase by at least 12% and 200 milliliters.
(11) “Flavoring” means any substance which is intended primarily to impart flavor to food products.
(12) “Flavor Worker Initial Questionnaire” means the full-length questionnaire contained in Appendix B1 of this section.
(13) “Flavor Worker Follow-Up Questionnaire” means the shorter questionnaire contained in Appendix B2 of this section.
(14) “Food product” means any substance, other than a substance used primarily for the purpose of imparting flavor, intended to be consumed by humans or animals.
(15) “Limit of detection (LOD)” means the lowest air concentration level of a substance that can, with 99% confidence, be determined to be statistically different from a sample blank.
(16) “Medical guidelines” means the following documents which are hereby incorporated by reference:
(A) CDPH Guidelines
(B) American Thoracic Society Guidelines
(C) Spirometric Reference Values
(17) NIOSH means the National Institute for Occupational Safety and Health, United States Centers for Disease Control and Prevention.
(18) “Open process” means any process that does not meet the definition of “enclosed process.”
(19) “OSHA method” means OSHA Sampling and Analytical Method #1013 for diacetyl and acetoin, published September, 2008, which is hereby incorporated by reference.
(20) “OSHA reliable quantitation limit or (OSHA RQL)” means the airborne concentration published as the reliable quantitation limit of the OSHA Method. This is 0.012 ppm (0.041 mg/m3) as a 180-minute Time-Weighted Average (TWA) or 0.035 ppm (0.12 mg/m3) as a 15-minute short term average.
(21) “Other artificial butter flavoring” means any flavoring containing diacetyl trimer [CAS #18114-49-3], acetoin [CAS #513-86-0], 2,3 pentanedione [CAS #600-14-6 ], 2,3 hexanedione [CAS #3848-24-6], or 2,3 heptanedione [CAS #96-04-8].
(22) “PLHCP” means physician or other licensed health care professional who is an individual whose legally permitted scope of practice (i.e., license, registration, or certification) allows him or her to independently provide or be delegated the responsibility to provide some or all of the health care services required by this section.
(23) “Process” means an activity or combination of activities that at any stage cools, heats, sprays, mixes, blends, transfers, or otherwise utilizes diacetyl or diacetyl-containing flavorings or food products in the preparation or manufacture of flavorings or food products. For purposes of this standard any interconnected group of vessels that utilizes diacetyl or diacetyl-containing flavorings or food products at any stage shall be considered a single process. Cleaning or sanitizing is considered a distinct process, and spill cleanup is also considered a distinct process.
(24) “Program reviewer” means a certified industrial hygienist or licensed professional engineer who is knowledgeable in both industrial ventilation design and the control of hazardous exposures, and who is responsible for certifying the effectiveness of the employer's diacetyl control program in accordance with subsection (e)(6).
(25) “Regulated area” means an area demarcated by the employer in which employees are potentially exposed to levels of diacetyl above the OSHA RQL or an area in which one or more open processes are located.
(26) “Reliable quantitation limit (RQL)” means the smallest concentration of analyte which can be quantitated precisely, providing that the recovery is 100 + 25% of the theoretical value.
(27) “Signs or symptoms of diacetyl related disease” means persistent irritation of the eyes, nose, throat, or upper or lower respiratory tract, or persistent chest tightness, shortness of breath, cough or wheezing.
(28) “Spirometric Reference Values” means the values set forth in the article titled “Spirometric Reference Values from a Sample of the General U.S. Population” by Hankinson, JL, Odencrantz, JR, and Fedan, KB published in 1999 in the American Journal of Respiratory and Critical Care Medicine, Volume 159, pages 179-187.
(29) “Supervising physician” means the occupational or pulmonary medicine physician described in subsection (g)(1)(A) who is: a) knowledgeable about spirometry, obstructive pulmonary disease, surveillance for occupational disease, the diagnosis and management of occupational disease, and the requirements of this standard; and b) responsible for ensuring compliance with all the medical program requirements described in subsection (g), (h), and (i) of this standard, as well as all applicable medical guidelines.
(30) “Temporary regulated area” means, a) an area that contains an enclosed process but in which exposure to airborne diacetyl or diacetyl-containing flavorings or food products may occur because part or all of the process is temporarily opened, or b) an area in which exposures to levels of diacetyl above the OSHA RQL may reasonably be expected to occur due to a spill, leak, or process upset.
(c) Exposure assessment.
(A) A determination of the concentration of airborne diacetyl to which each employee is exposed as an 8-hour time weighted average (TWA) and as a short term exposure, as described in subsections (c)(1)(B) and (c)(1)(C), shall be made from air samples that are representative of the employee's exposure without regard to the employee's use of respiratory protective equipment. The employer shall follow the instructions in Appendix A and shall utilize the OSHA Method or an equivalent method. Any individual sample in which the backup tube contains more than 20% of the amount of diacetyl on the front tube shall be evaluated for the possibility of sample overloading. Cleaning and sanitizing shall be monitored separately from production processes. The employer shall ensure that personal samples include samples that are taken during operations and periods of operations when there is reason to believe exposures are high, such as when tanks or containers are opened, filled, unloaded or cleaned; when process equipment is opened; and when diacetyl or diacetyl-containing flavorings or food products are heated or sprayed.
(B) To determine an 8-hour TWA, the employer shall collect full shift (for at least 7 hours during that shift) personal samples for at least one employee per shift for each job classification and for each process in each work area. If the total duration in which processes involving diacetyl or diacetyl-containing flavorings or food products is less than seven hours, then a representative assessment is the full duration of the employee's exposure on that day.
(C) The employer shall collect personal short term exposure samples to represent the highest likely 15-minute exposure(s) to airborne diacetyl for each process. One or more short term exposure sample shall be collected for at least one employee per shift for each job classification and for each process in each work area.
(2) Initial Monitoring.
(A) Within 60 days following the effective date of this standard, each employer who has a place of employment or work operation covered by this standard shall monitor each process to accurately determine the 8-hour TWA and the short term exposure levels of airborne diacetyl to which employees may be exposed, in accordance with subsection (c)(1).
Exception to subsection (c)(2)(A): Employers need not conduct initial monitoring of a process for which monitoring was performed within six months prior to the effective date of this standard provided that the monitoring was conducted in accordance with subsection (c)(1).
(B) Monitoring To Verify That A Process Is Enclosed. When the program reviewer determines that a process is enclosed (based on its design and construction), the employer shall:
1. Conduct an inspection to determine if there are any visible emissions
2. Monitor that process using a combination of area and personal sampling to verify that no levels of diacetyl above the OSHA RQL are present in the immediate or other work areas.
3. All monitoring shall be in accordance with Appendix A and the OSHA Method or equivalent method.
4. If the program reviewer determines that the design and construction of the process is enclosed, there are no visible emissions, and that monitoring has not found levels of diacetyl above the OSHA RQL, then the employer may consider that process to be enclosed for the purposes of this standard.
(C) Monitoring For Regulated Areas. When a regulated area is established due to the presence of an open process, the employer shall conduct, in accordance with Appendix A and the OSHA Method or equivalent method, a combination of area and personal sampling to determine whether there are levels of diacetyl above the OSHA RQL in the regulated area and in areas adjacent to regulated areas.
(3) Periodic Monitoring. Exposure monitoring required by subsection (c)(2) shall be repeated at least annually.
(4) Additional Monitoring. Additional representative monitoring which complies with subsections (c)(1) and (c)(2) shall be conducted within 30 days to evaluate the exposure of all potentially affected employees whenever:
(A) A new process is initiated;
(B) There is any change in process, or production, or in a control measure that may result in new or increased exposures to airborne diacetyl.
(5) Employee Notification.
(A) Within five working days of the employer's receipt of monitoring results, and no later than 30 days after the monitoring was conducted, the employer shall notify each employee in writing of the results which represent that employee's exposure.
(B) Whenever the monitoring results representative of an employee's exposure indicate that the employee's exposure was in excess of the OSHA RQL, the written notice shall include a statement that the OSHA RQL was exceeded and shall also include a description of any corrective actions taken to reduce the employee's exposure to or below the OSHA RQL if such measures are different from those already in place.
(d) Regulated areas.
(A) The employer shall establish a regulated area for each process using diacetyl or diacetyl-containing flavorings or food products unless the process is enclosed.
(B) A temporary regulated area complying with the requirements of this subsection shall be established during any period in which:
1. An enclosed process is opened, or
2. There is a spill, leak, or process upset that could reasonably be expected to result in airborne concentrations of diacetyl above the OSHA RQL or could reasonably be expected to result in exposures to diacetyl-containing powders. The temporary regulated area shall be maintained until the spill, leak, or process upset has been repaired and all spilled or leaked diacetyl-containing materials have been cleaned up and removed.
(2) The regulated area shall be clearly demarcated from the rest of the workplace by signs or other effective means.
(3) Access. Access to regulated areas shall be limited to authorized persons. Regulated areas shall be designed or configured so as to minimize the number of employees required to enter or pass through the area.
(4) Supervision. The regulated area shall be supervised by a person designated by the employer, who is knowledgeable about the employer's procedures for controlling exposures to diacetyl, and who has the authority necessary to take prompt measures to correct diacetyl related hazards. The supervisor shall ensure that:
(A) The name and employee identifier of each person who enters the regulated area is recorded on a daily log. These logs shall be maintained as employee exposure records in accordance with Section 3204.
(B) Each person who enters the regulated area has been trained in accordance with this section.
(C) Each person who enters the regulated area utilizes the personal protective equipment and respirators that are required for that area.
(D) The employer's control measures to minimize employee exposure to airborne diacetyl are followed.
(e) Engineering Controls and Work Practices.
(1) The employer shall implement engineering controls and work practices to reduce employee exposure to airborne diacetyl to the lowest levels feasible.
(2) The employer shall utilize measures to minimize vapor, mist and dust exposure to diacetyl including:
(A) Capturing vapors, mists, powders, and dusts by utilizing local exhaust ventilation or by enclosing the process; and,
(B) Minimizing where practicable the application of heat to processes where heat can contribute to exposure to airborne diacetyl; and,
(C) Use of other control methods such as isolation of the processing area from the rest of the workplace using walls, doors or other barriers, or use of cold storage of bulk materials, as applicable.
(3) The employer shall prohibit the following practices:
(A) The use of compressed air to remove pastes, powders or liquids that contain diacetyl from surfaces, clothing or equipment.
(B) The opening of pressurized vessels containing diacetyl until the vessels have been depressurized.
(C) Dry sweeping of materials that contain diacetyl.
(4) The employer shall implement procedures to protect employees in the event of an uncontrolled release of diacetyl or diacetyl-containing flavorings or food products.
(5) The employer shall establish and implement a written diacetyl control program describing how the engineering controls and work practices limit exposures to airborne diacetyl to the lowest feasible level. This written program shall include at least the following:
(A) A description of each process in which diacetyl or diacetyl-containing flavorings or food products are used, including equipment, material processed, control measures, crew size, operating procedures and maintenance practices;
(B) Any engineering plans or studies used to determine methods selected for controlling exposure to airborne diacetyl;
(C) An evaluation of the technology alternatives considered in achieving the lowest feasible exposures;
(D) All diacetyl measurements and monitoring data, including information about or measurements of the concentration of diacetyl in the bulk material;
(E) A detailed schedule for implementation of any engineering controls, work practices and any other control measures that cannot be implemented immediately. The reasons for any delays in implementation of the schedule or for any changes to the schedule shall be documented in writing.
(6) Program evaluation. A program evaluation shall be performed by the employer and then validated by a program reviewer. The program reviewer shall certify in writing that, in their professional judgment, each of the following is true:
(A) The employer's diacetyl control program is adequate to reduce employee exposure under worst-case conditions of use to below the OSHA RQL or, if that is not achievable, to as low a level as feasible. This determination shall be without regard to employee use of respiratory protective equipment.
(B) The program's control methods will prevent airborne diacetyl contamination outside the regulated areas, as measured by monitoring meeting the requirements of subsection (c) of this section.
(C) Processes considered enclosed for the purposes of this standard are in fact enclosed by design and construction, there are no visible emissions, and monitoring meeting the requirements of subsection (c) has detected that there are no emissions of diacetyl from the process into any areas of the workplace that result in airborne concentrations above the OSHA RQL.
(D) When respirator use is not to be required in a regulated area, the design and construction of control measures are sufficient to prevent employee exposures to levels of airborne diacetyl above the OSHA RQL, as verified by exposure monitoring conducted in accordance with subsection (c) and that there are no diacetyl-containing powders in the area.
(E) All required respirator use is fully compliant with subsections (f)(2) and (f)(3).
(f) Respiratory Protection.
(1) The employer shall provide, and ensure that employees use, respirators in accordance with Section 5144 whenever:
(A) An employee enters or works in a regulated area or a temporary regulated area.
EXCEPTION to subsection (f)(1)(A). Respirator use is not required in regulated areas in which:
1. There are no diacetyl-containing powders; and,
2. There has been an assessment conducted pursuant to subsection (c) that found no levels of airborne diacetyl above the OSHA RQL in the area; and
3. The program reviewer has certified, in accordance with subsection (e)(6), that the design and construction of the process and control measures are sufficient to prevent employee exposures to levels of airborne diacetyl above the OSHA RQL.
(B) Employees are exposed to airborne diacetyl or diacetyl-containing materials in operations for which monitoring has not been conducted or for which levels of airborne diacetyl above the OSHA RQL have been found, or are engaged in spill clean-up of diacetyl or diacetyl-containing materials.
(C) The employee is working in or adjacent to a regulated area or an area in which there is an enclosed process and has requested to use a respirator. This use shall be considered as required use for purposes of complying with Section 5144.
(2) Where a respirator is required by this section, the employer shall establish, implement and maintain a respiratory protection program in accordance with Section 5144 and the table in subsection (f)(3) below. Additional protection may be required where other contaminants are present, in accordance with Section 5144.
(3) Where the exposure assessment determines that exposures to diacetyl may exceed the OSHA RQL, either as a short term exposure or as an 8-hour TWA, or where diacetyl-containing powders are used, the employer shall provide respirators in accordance with the following table:
RESPIRATORY PROTECTION SELECTION TABLE
Type of Respirator1,3
Less than or equal to 0.2 ppm,
Half mask respirator4
no exposure to diacetyl-
Less than or equal to 0.5 ppm
Any powered air purifying respirator (PAPR)4
or supplied air respirator (SAR), or full
facepiece air purifying (APR)4
Less than or equal to 1.0 ppm,
Full facepiece APR or any tight-fitting PAPR4
Less than or equal to 20 ppm
Tight fitting full facepiece PAPR4 or SAR in
continuous flow or pressure demand mode, or
PAPR4 or SAR with helmet or hood in
continuous flow mode2 which have been found
to provide a protection factor of 1000
Above 20 ppm
Self-contained breathing apparatus (SCBA) in
pressure demand mode
Notes to Respiratory Protection Selection Table:
1. Employers may select respirators assigned for use in higher workplace concentrations for use at a lower concentration.
2. The employer must have evidence provided by the respirator manufacturer that testing of helmet/hood respirators demonstrates performance at a level of protection of 1000 or greater to permit use against concentrations of diacetyl greater than 0.5 ppm. Absent such testing, all other PAPRs and SARs with helmets/hoods may only be used for concentrations that do not exceed 0.5 ppm.
3. The respiratory protection program administrator or diacetyl program reviewer must decide the appropriate respirator from the table to provide employees protection from diacetyl-containing powders, taking into account powder concentrations and concentrations of any co-contaminants. The minimum level of respiratory protection for diacetyl-containing powders shall be any powered air-purifying respirator or supplied air respirator or full facepiece air purifying respirator.
4. The minimum acceptable air purifying respirator is one that provides both high efficiency particulate air filtration and also provides protection against organic vapors (as applicable, HEPA/OV cartridge, P100/OV cartridge).
(g) Medical Surveillance.
(A) The employer shall establish, implement and maintain a medical surveillance program for all employees identified in subsection (g)(2). The program shall be under the supervision of an occupational or pulmonary medicine physician who is knowledgeable about spirometry, obstructive pulmonary disease, surveillance for occupational disease, the diagnosis and management of occupational disease, and the requirements of this standard. The supervising physician shall be responsible for ensuring all components of the program meet the requirements of this standard and comply with the medical guidelines.
(B) All components of the program shall be administered confidentially by a PLHCP and provided during the employee's normal working hours or at a time and place convenient to the employee and shall be administered in a manner that ensures that the employee understands its content. All required components of the PLHCP evaluation shall be made available in a language the employee can read, or the subject matter shall be covered in an interview with the PLHCP. If the PLHCP is not fluent in the employee's language, the employer shall request that the PLHCP provide an interpreter. For the purposes of this standard “interpreter” means a person fluent in English and in the necessary second language, who can accurately speak, read, and readily interpret the necessary second language, or a person who can accurately sign and read the employee's sign language. Interpreters shall have the ability to translate the names of body parts and to describe competently symptoms and injuries in both languages. Interpreters may include, but are not limited to, members of the PLHCP's medical or professional staff.
(C) The employer shall provide the employee with an opportunity to discuss all components of the medical surveillance program and evaluation results with the PLHCP.
(D) The program shall include an initial medical evaluation, follow-up and termination or reassignment medical evaluations, and reports from the PLHCP. All medical evaluations, including all tests, shall be provided and assessed in accordance with the medical guidelines.
(2) The medical surveillance program shall include every employee who:
(A) Reports signs or symptoms of diacetyl related disease, or
(B) Has been in an area in which an uncontrolled release of diacetyl or diacetyl-containing materials has occurred, or
(C) Enters, for any portion of a day on 14 or more different days (as a cumulative total) within any 12 month period, any of the following areas:
1. A regulated area (including a temporary regulated area).
2. An area containing an open process.
3. An area containing levels of diacetyl above the OSHA RQL.
(3) Initial medical evaluation. Each employee identified under subsection (g)(2)(C) shall be provided with an initial medical evaluation that focuses on detecting and preventing respiratory disease. Prior to the provision of the initial medical evaluation, employees shall be trained pursuant to subsection (j). When feasible, the initial medical evaluation shall be provided prior to the employee's assignment to an area in which medical surveillance is required. In no case shall the initial medical evaluation occur later than 14 calendar days after the employee has met the criteria in subsection (g)(2)(C). Any employee not previously provided an initial medical evaluation who develops signs or symptoms of diacetyl related disease or who has been in an area in which an uncontrolled release of diacetyl or diacetyl-containing materials has occurred, shall be provided with an initial medical evaluation as soon as practicable, and in no case later than 10 working days following report of the signs or symptoms or after the exposure to the uncontrolled release.
The initial evaluation shall include:
(A) Employee completion and PLHCP evaluation of a detailed occupational history that includes past and current work exposure to flavorings and other substances known or suspected to be respiratory hazards.
(B) Employee completion and PLHCP evaluation of a respiratory health questionnaire that is at least as comprehensive as the Flavor Worker Initial Questionnaire in Appendix B1.
(C) Spirometry conducted and evaluated in accordance with the American Thoracic Society Guidelines or equivalent and administered by technicians who:
1. have successfully completed a NIOSH-certified initial course in spirometry,
2. maintain a valid NIOSH-approved spirometry course training certificate, and
3. have demonstrated to the supervising physician knowledge of proper techniques for coaching test subjects.
(D) Appropriate additional tests as necessary, in the opinion of the evaluating PLHCP.
(4) Follow-up evaluations.
(A) No less frequently than every six months and whenever recommended by the PLHCP, the employer shall provide a follow-up medical evaluation that includes each of the elements listed below:
1. Spirometry meeting the requirements of subsection (g)(3)(C);
2. Employee completion and PLHCP evaluation of a questionnaire at least as comprehensive as the Flavor Worker Follow-Up Questionnaire in Appendix B2;
3. Appropriate additional tests as necessary in the opinion of the evaluating PLHCP.
(B) Whenever an employee reports to the employer signs or symptoms of diacetyl related disease, or has been in an area in which an uncontrolled release of diacetyl or diacetyl-containing materials has occurred, the employer shall provide the employee with a follow-up medical evaluation meeting the requirements of subsection (g)(4)(A) as soon as practicable, and in no case later than 10 working days following report of the signs and symptoms or 10 working days after the exposure to the uncontrolled release.
(C) An employee who is in the medical surveillance program as a result of a spill, leak, or process upset shall have a follow-up evaluation within six months, meeting the requirements of subsection (g)(4)(A) and shall receive further follow-up evaluations as recommended by the PLHCP. The employee shall remain in the medical surveillance program for not less than 12 months.
(5) Termination of Employment or Reassignment. Whenever an employee who has been a participant in this medical surveillance program terminates employment with the employer or is reassigned to a job that does not require medical surveillance in accordance with subsection (g)(2), the employer shall provide a follow-up medical evaluation meeting the requirements of subsection (g)(4)(A), unless the employee has had a follow-up evaluation within the previous 30 calendar days. Reassigned employees shall be provided with follow-up medical evaluations as required by subsection (g)(4) for a minimum of 12 months following reassignment.
(6) Information Provided to the PLHCP. The employer shall provide the following information to the evaluating PLHCP:
(A) A copy of this standard and its appendices.
(B) A copy of the medical guidelines.
(C) A description of the employee's duties as they relate to the employee's exposure to diacetyl, diacetyl-containing flavorings or food products, and other flavorings.
(D) The employee's actual or representative breathing zone exposure levels.
(E) A description of any personal protective equipment used or to be used.
(F) For employees who will use respirators, the information required by Section 5144(e)(5) of these Orders.
(G) The written opinion from any previous medical evaluations.
(H) A listing of any spills, leaks or process upsets to which the employee had been exposed. The employer shall additionally provide a description of such events including any measurements or indications of exposure resulting from the event.
(7) Change of Supervising Physician. If the employer changes supervising physician, the employer shall take all reasonable steps to ensure that all records of medical surveillance, including spirometry results, are transferred to the new supervising physician.
(h) PLHCP Written Opinion.
(1) For each initial, follow-up, termination of employment or reassignment evaluation required under this standard, the employer shall obtain a written opinion from the PLHCP within 15 days of the evaluation. This written opinion shall include only the following information:
(A) A list of any limitations on respirator use related to the medical condition of the employee, or relating to the workplace conditions in which the respirator will be used, including whether or not the employee is medically able to use the respirator.
(B) A list of any recommended limitations on the employee's exposures to diacetyl or other flavoring substances or ingredients, on the employee's use of personal protective equipment, or on the employee's performance of specific tasks.
(C) A conclusion concerning whether medical conditions may have resulted from exposure to diacetyl or other potentially hazardous flavoring constituents or from exposure in an emergency, and whether there is a need for further evaluation.
(D) The PLHCP's recommendation, in accordance with subsection (i), regarding whether the employee should be removed from particular job assignments and/or any necessary modification of jobs to which the employee is assigned.
(E) A statement that the employee has been informed of any medical conditions which would be aggravated by exposure to diacetyl or other flavoring constituents.
(2) The employer shall provide a copy of the PLHCP's written opinion to the employee within 5 calendar days of its receipt. This opinion shall also include a notice of the right of the employee to seek a second medical opinion in accordance with the provisions of subsection (i)(4), including the requirement for the employee to inform the employer in writing if the employee is requesting that the employer pay for a second medical opinion.
(i) Medical Removal.
(1) When the PLHCP recommends an employee's removal from a job assignment or recommends modification of an employee's job to reduce exposure, the employer shall:
(A) Modify the employee's job or transfer the employee to comparable work for which the employee is qualified or can be trained in a short period (up to six months). The employer shall maintain the employee's current earnings, seniority, and other benefits. If there is no work available that would not involve the employee being exposed to diacetyl or other potentially hazardous flavoring constituents, the employer shall maintain the employee's current earnings, seniority and other benefits until any of the following occurs:
1. Such work becomes available.
2. The employee is determined by the PLHCP, or is determined in accordance with subsection (i)(4), to be able to return to his or her original job status.
3. The employee is determined by the PLHCP, or is determined in accordance with subsection (i)(4), to be permanently unable to return to work involving exposure to diacetyl or other potentially hazardous flavoring constituents.
4. Six months have elapsed since the beginning of the current medical removal period.
(B) Provide competent medical counseling on the increased risk of significant health impairment for employees with medical conditions that may be directly or indirectly aggravated by exposure to diacetyl or other potentially hazardous flavoring constituents.
(2) Workers' Compensation Claims. If a removed employee files a claim for workers' compensation for a diacetyl-related disability, then for up to a maximum of six months pending final disposition of the claim, the employer shall continue to provide medical removal protection benefits. To the extent that an award is made to the employee for earnings lost during the period of removal, the employer's medical removal payment obligation shall be reduced by such amount. The employer shall receive no credit for workers' compensation payments received by the employee or a health care provider for treatment related expenses.
(3) Other Credits. The employer's obligation to provide medical removal protection payments to a removed employee may be reduced by the amount that the employee receives in compensation for:
(A) Earnings lost during the period of removal from a publicly or employer-funded compensation program, or
(B) Income received from employment with another employer made possible by virtue of the employee's removal.
(4) Multiple Physician Review.
(A) After any medical evaluation or consultation conducted pursuant to subsection (g), the employee may designate an independent physician to review any findings, determinations or recommendations and to conduct such examinations, consultations, and laboratory tests as this second physician deems necessary and appropriate to facilitate this review.
(B) The employer may condition its payment for the employee designated physician in the multiple physician review mechanism upon the employee doing the following within fifteen (15) days after receipt of the notification of the right to seek a second medical opinion, or receipt of the initial PLHCP's written opinion, whichever is later:
1. The employee informs the employer in writing of the intention to seek a second medical opinion, and
2. The employee initiates steps to make an appointment with a second physician.
(C) If the findings, determinations or recommendations of the second physician differ from those of the initial PLHCP, then the employer and the employee shall assure that efforts are made for the initial PLHCP and the second physician to resolve the disagreement. If they are unable to quickly resolve their disagreement, then the employer and the employee through their respective physicians shall designate a third physician who shall be a specialist in the field at issue:
1. To review the findings, determinations or recommendations of the initial PLHCP and the second physician; and
2. To conduct such examinations, consultations, laboratory tests and discussions with the prior PLHCP and physician as the third physician deems necessary to resolve the disagreement.
(D) In the alternative, the employer and the employee or authorized employee representative may jointly designate such third physician.
(E) The employer shall act consistent with the findings, determinations and recommendations of the third physician, unless the employer and the employee reach an agreement which is otherwise consistent with the recommendations of at least one of the three physicians.
(j) Information, Training and Labeling.
All information, training material and labeling shall be appropriate in content and vocabulary to the educational level, literacy, and language of employees.
(1) Information and Training. The employer shall ensure that all employees in workplaces covered by this standard participate in a training program which must be provided during working hours.
(A) Awareness Training. All employees in workplaces covered by this standard must receive awareness training, including employees (such as office workers) not likely to be directly exposed to flavorings. Awareness training shall include information on the health effects of exposure to diacetyl and diacetyl-containing flavorings or food products, the location and description of processes in which diacetyl or diacetyl-containing flavorings or food products or other artificial butter flavorings are used, the location of any regulated areas and the fact that employees are prohibited from entering those areas unless they are protected as required.
(B) Additional Training.
Training for employees at the time of initial assignment to areas in which exposure to diacetyl or diacetyl-containing flavorings or food products or other artificial butter flavoring are present shall be provided pursuant to subsections 1 and 2 below:
1. Frequency of training shall be as follows:
a. At the time of initial assignment to tasks where exposure to diacetyl or diacetyl-containing flavorings or food products or other artificial butter flavoring may take place. Training for employees must take place prior to their entry into regulated areas.
b. Annual training shall be provided within one year of the employee's previous training.
c. Employers shall provide additional training when changes, such as introduction of new engineering, administrative or work practice controls, modification of tasks or procedures or institution of new tasks or procedures may affect the employee's exposure. The additional training may be limited to addressing the new exposures created and the use of new or modified equipment and control measures.
2. The training program shall contain at a minimum the following elements:
a. An explanation of the operations that result in or are reasonably likely to result in exposure to airborne diacetyl, and diacetyl-containing flavorings or food products or other artificial butter flavoring;
b. The results of exposure monitoring or other exposure assessments and the right of employees to obtain copies of this information in accordance with this Section and Section 3204 of these Orders;
c. The limitations of current exposure monitoring methods for detection of diacetyl-containing powders and mists.
d. A description of the employer's medical surveillance program. This description shall include the adverse health effects and signs or symptoms of diacetyl related disease and the need for employees to recognize and report these health effects and signs or symptoms promptly to the employer if they experience any of them. This information shall also describe the mechanism by which employees are to report the occurrence of the signs or symptoms to the employer. This description and information shall also include any Health Hazard Alerts pertaining to the health effects of diacetyl or food flavorings that are produced by the CDPH Occupational Health Branch, including by its Hazard Evaluation System and Information Service (HESIS: http://www.cdph.ca.gov/programs/hesis/Pages/default.aspx). Employees shall be encouraged to report any of these signs or symptoms to their employer.
e. The engineering controls, work practices, labeling, and personal protective equipment associated with the employee's job assignment and how they should be used to reduce exposure to diacetyl and diacetyl containing materials. This shall include the means of demarcating regulated areas, and requirements for entry into those areas.
f. For employees who use respirators or who enter regulated areas, training shall also be provided in accordance with Section 5144 of these Orders.
(2) Labeling Containers in the Workplace.
(A) In addition to any labeling required by the Food and Drug Administration, Section 5194 of these Orders and other standards, the employer shall ensure that any container of diacetyl or diacetyl-containing flavoring or food product to be used within the workplace is labeled with the following warning which shall also be translated into any language necessary to be understood by each employee in the workplace:
WARNING: This product contains diacetyl which can be a severe respiratory hazard. Breathing dust, powder, mist or vapor from this product could result in irritation of the eyes and respiratory tract and in permanent lung damage.
(B) Containers of other artificial butter flavoring to be used in the workplace shall be labeled with the following warning which shall also be translated into any language necessary to be understood by each employee in the workplace:
WARNING: This product contains an artificial butter flavoring other than diacetyl. The health effects of these materials selected as substitutes for diacetyl are currently being studied for potential respiratory hazards. Avoid eye contact or breathing dust, powder, mist or vapor from this product as irritation of the eyes or respiratory tract may result.
(C) In lieu of affixing the warning labels required by subsections (j)(2)(A) and (B) to individual stationary process containers, the employer may use color coding, signs, placards, process sheets, batch tickets, operating procedures, or other such written materials as long as the alternative method identifies the containers to which it is applicable and effectively conveys the warning information to employees.
(k) Recordkeeping and Reporting.
(1) The employer shall maintain and provide access to all exposure and medical records in accordance with Section 3204. Entry logs for regulated areas shall be maintained as employee exposure records in accordance with Section 3204. Records of training shall be maintained for at least three years. Records of assessments of ventilation systems shall be created and maintained in accordance with Section 5143 of these Orders.
(2) Within 24 hours of becoming aware of any flavor-related diagnosis of fixed obstructive lung disease, the employer shall report the diagnosis to the Chief at the following address:
REPORT OF FIXED OBSTRUCTIVE LUNG DISEASE
C/O RESEARCH AND STANDARDS HEALTH UNIT
DIVISION OF OCCUPATIONAL SAFETY AND HEALTH
POST OFFICE BOX 420603
SAN FRANCISCO, CALIFORNIA 94142
(3) All employers covered by this standard shall report any use of diacetyl in writing to the Chief within 60 calendar days of the effective date of this standard. New users shall report such new use to the Chief within 15 calendar days of the new use.
(A) Reports of Use shall be sent to:
RESEARCH AND STANDARDS HEALTH UNIT
DIVISION OF OCCUPATIONAL SAFETY AND HEALTH
POST OFFICE BOX 420603
SAN FRANCISCO, CALIFORNIA 94142
(B) The Report of Use shall include:
1. The name of the employer and address of each workplace where diacetyl or diacetyl-containing materials are in use;
2. A description that identifies where the use of diacetyl or diacetyl-containing materials is located in the workplace;
3. A brief description of each process or operation which creates employee exposure to the diacetyl, as well as the estimated number of employees engaged in each process or operation; and
4. The names and addresses of any collective bargaining units or other representatives of the affected employees.
(C) Posting. A copy of the written report of use shall be posted where the diacetyl or diacetyl-containing material is in use or other appropriate location where the posting is conspicuous to affected employees. The report shall be posted until the use no longer takes place at the worksite.
Note: Authority cited: Section 142.3, Labor Code. Reference: Section 142.3, Labor Code.
1. New section filed 11-2-2010; operative 12-2-2010 (Register 2010, No. 45).
Section 5197 - Appendix A Section
5197 - Appendix B1 Section 5197 - Appendix B2
Go Back to Article 109 Table of Contents